Delivery Order SPE2DB20D2104-SPE2DB25FMAMF

Award Date 10/15/24
Potential Completion Date 10/16/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,226.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a completion date of August 16, 2024. The contract was awarded on August 15, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen is a major supplier of pharmaceutical products and...
This federal contract award, with an ID of SPE2DB24D3014|SPE2DB25FKRVP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.68 firm fixed-price delivery order is for the supply of Reyvow 50 mg tablets, with a performance period running through October 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDYJV, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,223.20 firm fixed price delivery order is for the supply of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award is a delivery order worth $1,020.98 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FM97V, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,226.28 delivery order contract is for the supply of the medication Reyvow 100 mg tablet, with an ultimate completion date of October 26, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,656.99 and is a Firm Fixed Price Delivery Order for medical supplies, specifically the product "REYVOW 100 MG TABLET UD 8S." The contract has a completion date of February 10, 2025 and was awarded on February 7, 2025. The contract is not designated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,268.67, is a delivery order for the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN45C, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, with a ceiling value of $2,155.61 and a completion date of January 30, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,226.28 firm fixed-price delivery order is for the supply of REYVOW 50 MG TABLET UD 8S, a prescription medication. The contract has an ultimate completion date of June 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,729.58, is for the delivery of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product. This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which serves as a primary vehicle for...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMAMF
    Delivery Order

This federal contract award with ID SPE2DB20D2104|SPE2DB25FMAMF was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,099.83 firm-fixed-price Delivery Order is for the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of October 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical supplies and medications to support various government healthcare programs and military treatment facilities. This contract is not designated as a set-aside.

Generated 1/14/25, 9:25 AM